Healthcare provider profile · identity verified

George William Bounds, M.D.

Internal Medicine · NASHVILLE, TN · NPI 1477598712

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	600	166
Atorvastatin Calcium	Atorvastatin Calcium	590	170
Losartan Potassium	Losartan Potassium	391	108
Rosuvastatin Calcium	Rosuvastatin Calcium	375	109
Levothyroxine Sodium	Levothyroxine Sodium	365	94
Metoprolol Succinate	Metoprolol Succinate	297	82
Omeprazole	Omeprazole	293	84
Gabapentin	Gabapentin	231	49
Metformin Hcl	Metformin Hcl	229	66
Alprazolam	Alprazolam	205	42
Potassium Chloride	Potassium Chloride	200	57
Pantoprazole Sodium	Pantoprazole Sodium	171	45
Furosemide	Furosemide	160	50
Ozempic	Semaglutide	158	27
Sertraline Hcl	Sertraline Hcl	149	46
Ezetimibe	Ezetimibe	140	42
Lisinopril	Lisinopril	137	38
Hydrochlorothiazide	Hydrochlorothiazide	136	35
Zolpidem Tartrate	Zolpidem Tartrate	136	29
Tamsulosin Hcl	Tamsulosin Hcl	132	36
Escitalopram Oxalate	Escitalopram Oxalate	131	38
Metformin Hcl Er	Metformin Hcl	130	35
Montelukast Sodium	Montelukast Sodium	118	32
Alendronate Sodium	Alendronate Sodium	117	32
Pravastatin Sodium	Pravastatin Sodium	115	32
Tramadol Hcl	Tramadol Hcl	104	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	99	27
Metoprolol Tartrate	Metoprolol Tartrate	81	21
Allopurinol	Allopurinol	76	22
Azithromycin	Azithromycin	76	62
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	73	14
Atenolol	Atenolol	70	18
Trazodone Hcl	Trazodone Hcl	66	19
Duloxetine Hcl	Duloxetine Hcl	64	19
Simvastatin	Simvastatin	64	19
Albuterol Sulfate Hfa	Albuterol Sulfate	63	23
Repatha Sureclick	Evolocumab	61	suppressed
Eliquis	Apixaban	56	15
Chlorthalidone	Chlorthalidone	54	17
Clopidogrel	Clopidogrel Bisulfate	54	18
Synthroid	Levothyroxine Sodium	54	15
Diazepam	Diazepam	53	suppressed
Citalopram Hbr	Citalopram Hydrobromide	50	14
Donepezil Hcl	Donepezil Hcl	50	14
Mirtazapine	Mirtazapine	49	11
Meloxicam	Meloxicam	46	20
Venlafaxine Hcl Er	Venlafaxine Hcl	46	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	45	35
Telmisartan	Telmisartan	45	13
Esomeprazole Magnesium	Esomeprazole Magnesium	44	suppressed
Lorazepam	Lorazepam	44	suppressed
Spironolactone	Spironolactone	44	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	43	14
Clonazepam	Clonazepam	42	suppressed
Pregabalin	Pregabalin	42	suppressed
Fluticasone Propionate	Fluticasone Propionate	41	16
Prednisone	Prednisone	41	32
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	39	11
Fluoxetine Hcl	Fluoxetine Hcl	38	suppressed
Carvedilol	Carvedilol	37	12
Olmesartan Medoxomil	Olmesartan Medoxomil	36	suppressed
Ondansetron Odt	Ondansetron	35	13
Bupropion Xl	Bupropion Hcl	34	suppressed
Meclizine Hcl	Meclizine Hcl	34	15
Pitavastatin Calcium	Pitavastatin Calcium	33	suppressed
Eszopiclone	Eszopiclone	31	suppressed
Hydrocortisone	Hydrocortisone	31	suppressed
Jardiance	Empagliflozin	30	15
Tizanidine Hcl	Tizanidine Hcl	30	suppressed
Colesevelam Hcl	Colesevelam Hcl	29	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Rybelsus	Semaglutide	29	suppressed
Promethazine Hcl	Promethazine Hcl	27	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Famotidine	Famotidine	26	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Memantine Hcl	Memantine Hcl	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Colchicine	Colchicine	24	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Livalo	Pitavastatin Calcium	24	suppressed
Nebivolol Hcl	Nebivolol Hcl	24	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Levetiracetam	Levetiracetam	23	suppressed
Levofloxacin	Levofloxacin	23	suppressed
Ramipril	Ramipril	23	suppressed
Sotalol	Sotalol Hcl	22	suppressed
Verapamil Er	Verapamil Hcl	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Folic Acid	Folic Acid	21	suppressed
Ipratropium Bromide	Ipratropium Bromide	21	suppressed
Fluconazole	Fluconazole	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Novolog Flexpen	Insulin Aspart	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	18	suppressed
Lansoprazole	Lansoprazole	18	suppressed
Linzess	Linaclotide	18	suppressed
Mounjaro	Tirzepatide	18	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	18	suppressed
Risedronate Sodium	Risedronate Sodium	18	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	15
Glipizide	Glipizide	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Amoxicillin	Amoxicillin	15	11
Azelastine Hcl	Azelastine Hcl	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	15	suppressed
Temazepam	Temazepam	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Divalproex Sodium	Divalproex Sodium	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Estradiol	Estradiol	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	13	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Torsemide	Torsemide	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Oxcarbazepine	Oxcarbazepine	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Praluent Pen	Alirocumab	11	suppressed
Testosterone	Testosterone	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error